http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9604610-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 1996-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4189b90d19fa0ea2444f857ffeaf08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f0794995559a2efe556150433665b1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5e6b152e7aa37e39f4cdbfc7c308edb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2abe520c88383a101ff4d521f4349d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc5c932cf52d1ba0d24554820cdd5043
publicationDate 1997-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9604610-A
titleOfInvention ESTER DERIVATIVES AND CARBAMATE OF AZOLONES ANTI-HELICOBACTER
abstract The present invention refers to a compound characterized in that it has the formula: a pharmaceutically acceptable acid addition salt or a stereochemically isomeric form thereof, where Y is CH or N; R1, R2 and R3 are each independently hydrogen or C1-4alkyl; R4 and R5 are each independently hydrogen, halogen, C1-4alkyl, C1-4alkyloxy, hydroxyl, trifluoromethyl, trifluoromethyloxy or difluoromethyloxy; R6 is C1-6alkyl, hydroxyC1-6alkyl, C1-4alkyloxy-C1-6alkyl, phenyl or phenyl-C1-4alkyl; Z is CO or CHOH.
priorityDate 1994-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 38.